Samsara BioCapital
Biotech Investor · 5 portfolio companies
Portfolio
5
Combined Value
$6.2B
Focus Areas
9
Top Stage
Phase 2
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Vera Therapeutics | $2.9B |
| Mineralys Therapeutics | $2.0B |
| MoonLake Immunotherapeutics | $1.2B |
| Nkarta | $152.0M |
| Alpheus Medical | — |